Article
Haemophilia, state of the art and new therapeutic opportunities, a regulatory perspective
27 Mar 2021
Abstract excerpt
Haemophilia A and B are rare bleeding disorders. Over the past decades, they have been transformed from debilitating diseases to manageable conditions in the Western world. However, optimizing haemophilia care remains challenging in developing countries. Several challenges and unmet needs remain in the treatment of the haemophilia limiting the QoL of patients. These challenges are now being addressed by extended...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
